Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 18/20 | 0.61 |
| ▸ | CTSS | P25774 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12734596 | 1.00 | CTSK (0.61) | CTSKCTSS | |
| SCHEMBL15961701 | 1.00 | CTSK (0.61) | CTSKCTSS | |
| SCHEMBL24739376 | 0.95 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL24465592 | 0.95 | CTSK (0.56) | CTSKCTSS | |
| SCHEMBL28398590 | 0.95 | CTSK (0.56) | CTSKCTSS | |
| Hydrochloric Acid SCHEMBL30306646 | 0.93 | CTSK (0.55) | CTSKCTSS | |
| SCHEMBL30464946 | 0.93 | CTSK (0.55) | CTSKCTSS | |
| SCHEMBL4781261 | 0.93 | CTSK (0.55) | CTSKCTSS | |
| SCHEMBL28599705 | 0.93 | CTSK (0.55) | CTSKCTSS | |
| SCHEMBL17980908 | 0.89 | CTSK (0.53) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022166860-A1 | PIM KINASE INHIBITOR | 杭州邦顺制药有限公司 | 2022-08-11 | — | — | WO | disclosed |
| WO-2020231766-A1 | AGONISTS OF ROR GAMMAt | BRISTOL-MYERS SQUIBB COMPANY (US) | 2020-11-19 | — | — | WO | disclosed |
| CN-107849052-A | Pyrrolo [ 2, 3-d ] pyrimidine compounds or salts thereof | 大鹏药品工业株式会社 | 2018-03-27 | — | — | CN | disclosed |
| CN-105980383-B | Azaindole derivatives | 大鹏药品工业株式会社 | 2017-07-04 | — | — | CN | disclosed |
| US-20110082133-A1 | PYRIDONE COMPOUNDS | ASTELLAS PHARMA INC. (JP) | 2011-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082133-A1 | PYRIDONE COMPOUNDS | PTGER4, P2RY4, PTGER1 | CTSK 3796/4885CTSS 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.